Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
EO14398; ASSESS SAFETY OF A MICRONEEDLE PATCH FOR VACCINATION AGAINST ROTAVIRUS WHEN GIVEN INTRADERMALLY FOR 4 ADMIN IN RATSDepartment of Health and Human Services$400.0K obligationsEnds Sep 14, 2027
"PARTICIPATION OF SOUTHERN RESEARCH INSTITUTE ON THE NESC NON-DESTRUCTIVE EVALUATION TECHNICAL DISCIPLINE TEAM"National Aeronautics and Space Administration$3.0K obligationsEnds Dec 31, 2020
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIESDepartment of Health and Human Services$32.5K obligationsEnds Jul 19, 2027
6.0 METER LOW EARTH ORBIT FLIGHT TEST OF AN INFLATABLE DECELERATOR (LOFTID) AEROSHELL DEPLOYABLE FLEXIBLE THERMAL PROTECTION SYSTEM (F-TPS) AND NOSE F-TPS ASSEMBLY FABRICATION…National Aeronautics and Space Administration$3.4M obligationsEnds Feb 28, 2021
NONCLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASESDepartment of Health and Human Services$2.4M obligationsEnds Apr 30, 2027
CONTRACT HHSN272201800006I; SOUTHERN RESEARCH INSTITUTE; MEDICINAL CHEMISTRY AND PROBLEM SOLVING SYNTHESIS FOR ANTIVIRALS; OA TASK 75N93021F00001; MIS TASK TOIA21B23OBRRTR3; BASE…Department of Health and Human Services$1.9M obligationsEnds Jan 31, 2026
NONDESTRUCTIVE EVALUATION OF POLYMER MATRIX COMPOSITES THROUGH COATINGSDepartment of Defense$3.7M obligationsEnds Feb 28, 2026
CONDUCT CONFIRMATORY AND SPECIALIZED IN VITRO TESTING AND SCREENING OF INTERVENTIONAL AGENTS IN STANDARD FORMATS (TASK AREA A).Department of Health and Human Services$289.5K obligationsEnds Aug 31, 2026
CONDUCT HIT-TO-LEAD PROGRESSION STUDIES ON INTERVENTIONAL AGENTS: IDENTIFICATION OF ANTI-HIV LEAD COMPOUNDSDepartment of Health and Human Services$403.5K obligationsEnds Aug 31, 2026
"MATERIAL CHARACTERIZATION FOR THE FABLAB PHASE A EFFORT FROM TECHSHOT AND INTERLOG,"National Aeronautics and Space Administration$51.7K obligationsEnds Feb 28, 2020
IGF::OT::IGF SUPPORT OF THE RESEARCH EFFORT TO EVALUATE TOXICITY FOLLOWING EARLY LIFE EXPOSURE TO TEST ARTICLES FOR THE NTPDepartment of Health and Human Services$29.1M obligationsEnds Sep 22, 2023
THE CONTRACTOR SHALL PERFORM ASSAY DEVELOPMENT AND VALIDATION TO IDENTIFY AND EVALUATE EFFICACY OF ANTI-HIV THERAPEUTICS AND TOPICAL MICROBICIDES. NOTE: THE VALIDATION PROCESS…Department of Health and Human Services$214.1K obligationsEnds Jul 31, 2022
TESTING OF MAP30-TAT X DEXAMETHASONE SAMPLES FOR INHIBITION OF COVID-19 BINDING TO ACE2 RECEPTOR IN CELL CULTURE NEEDED FOR STUDIES OF THIS VIRUS.Department of Health and Human Services$7.5K obligationsEnds Aug 31, 2022
IGF::OT::IGF HHSN271201100005I/HHSN27100015 - IND-ENABLING STUDIES - RUC4Department of Health and Human Services$1.7M obligationsEnds Nov 15, 2020
PCMID: DEVELOPMENT AND USE OF A NON-HUMAN PRIMATE MODEL OF SARS-COV-2 INFECTIONDepartment of Health and Human Services$1.0M obligationsEnds May 26, 2021
PRECLINICAL MODELS OF INFECTIOUS DISEASES, FERRET MODELS FOR THE EVALUATION OF INFLUENZA VACCINES AND VACCINE STRATEGIESDepartment of Health and Human Services$3.3M obligationsEnds Aug 31, 2022
IGF::OT::IGF QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCEDepartment of Health and Human Services$10.1M obligationsEnds Oct 1, 2021
DRUG DEVELOPMENT CONSULTANT SERVICES IN SUPPORT OF THE STEP UP FOR SUD PROGRAM. POP: 09/21/20-09/20/21.Department of Health and Human Services$215.5K obligationsEnds Sep 20, 2021
PHARMACOKINETICS OF LONG-ACTING PREPARATIONS OF TELACEBEC (Q203) IN SPRAGUE DAWLEY RATSDepartment of Health and Human Services$256.5K obligationsEnds Jun 30, 2025
PHARMACOKINETICS AND TOXICOLOGY DRF STUDIES - BLACKTHORNE LDTDepartment of Health and Human Services$440.0K obligationsEnds Dec 26, 2020